Gloomy outlook for US diagnostic imaging agents
This article was originally published in Clinica
The mood was bleak at the 10th annual symposium on Economics of Diagnostic Imaging, reports Clinica's Washington correspondent, Duffy Miller. While low osmolality (non-ionic) contrast agents (LOCA) are vastly safer than the older ionic contrast agents, they are also more expensive. "With the economic restraints that are being placed on the medical system in the US, there will be increasing pressure from many sources for reconversion to the less expensive ionic agents," Dr Mark Mishkin warned fellow radiologists at the Washington meeting on October 26th.